In situ trans-differentiation therapy effectively terminates the growth and recurrence of glioblastoma

被引：0
|
作者：
Zhao, Huihui
Li, Zhaozhong
Zhang, Xiaohui
Zhao, Congjian
Zhu, Zhao
Liu, Yueguang
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7229
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7229
引用
收藏
页数：2
相关论文
共 23 条
  • [21] Predictive Value of Tumor Recurrence Using Urinary Vascular Endothelial Growth Factor Levels in Patients Receiving Radiation Therapy for Glioblastoma
    Camphausen, K. A.
    Wang, M.
    Graves, C.
    Corn, B. W.
    Muanza, T. M.
    Howard, S. P.
    Mahadevan, A.
    Schultz, C. J.
    Haas, M. L.
    Mehta, M. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S181 - S181
  • [22] Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model
    Qiao, Tianyun
    Zhao, Jinbo
    Xin, Xiangbing
    Xiong, Yanlu
    Guo, Wenwen
    Meng, Fancheng
    Li, Hui
    Feng, Yangbo
    Xu, Hui
    Shi, Changhong
    Han, Yong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (05) : 1169 - 1181
  • [23] Correction to: Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model
    Tianyun Qiao
    Jinbo Zhao
    Xiangbing Xin
    Yanlu Xiong
    Wenwen Guo
    Fancheng Meng
    Hui Li
    Yangbo Feng
    Hui Xu
    Changhong Shi
    Yong Han
    Cancer Immunology, Immunotherapy, 2023, 72 : 1183 - 1183
123